Takeda Pharmaceutical Company TAK Stock
Takeda Pharmaceutical Company Price Chart
Takeda Pharmaceutical Company TAK Financial and Trading Overview
Takeda Pharmaceutical Company stock price | 14.38 USD |
Previous Close | 16.09 USD |
Open | 16.04 USD |
Bid | 16.02 USD x 3200 |
Ask | 16.4 USD x 3100 |
Day's Range | 16.04 - 16.17 USD |
52 Week Range | 12.28 - 17.15 USD |
Volume | 1.08M USD |
Avg. Volume | 2.14M USD |
Market Cap | 50.65B USD |
Beta (5Y Monthly) | 0.677011 |
PE Ratio (TTM) | 22.430553 |
EPS (TTM) | 0.44 USD |
Forward Dividend & Yield | 0.66 (4.09%) |
Ex-Dividend Date | September 29, 2022 |
1y Target Est | 18.98 USD |
TAK Valuation Measures
Enterprise Value | 4.43T USD |
Trailing P/E | 22.430553 |
Forward P/E | 8.156566 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.012576137 |
Price/Book (mrq) | 0.0079021575 |
Enterprise Value/Revenue | 1.101 |
Enterprise Value/EBITDA | 3.624 |
Trading Information
Takeda Pharmaceutical Company Stock Price History
Beta (5Y Monthly) | 0.677011 |
52-Week Change | 23.09% |
S&P500 52-Week Change | 20.43% |
52 Week High | 17.15 USD |
52 Week Low | 12.28 USD |
50-Day Moving Average | 16.48 USD |
200-Day Moving Average | 15.16 USD |
TAK Share Statistics
Avg. Volume (3 month) | 2.14M USD |
Avg. Daily Volume (10-Days) | 1.59M USD |
Shares Outstanding | 3.12B |
Float | 3.07B |
Short Ratio | 3.78 |
% Held by Insiders | 0% |
% Held by Institutions | 2.21% |
Shares Short | 7.93M |
Short % of Float | N/A |
Short % of Shares Outstanding | 0.25% |
Dividends & Splits
Trailing Annual Dividend Rate | 180 |
Trailing Annual Dividend Yield | 1118.70% |
5 Year Average Dividend Yield | 465.00% |
Payout Ratio | 0.4715 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2023 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | March 31, 2024 |
Profitability
Profit Margin | 7.87% |
Operating Margin (ttm) | 13.87% |
Gross Margin | 69.10% |
EBITDA Margin | 30.37% |
Management Effectiveness
Return on Assets (ttm) | 2.57% |
Return on Equity (ttm) | 5.26% |
Income Statement
Revenue (ttm) | 4.03T USD |
Revenue Per Share (ttm) | 1297.67 USD |
Quarterly Revenue Growth (yoy) | 9.50% |
Gross Profit (ttm) | N/A |
EBITDA | 1.22T USD |
Net Income Avi to Common (ttm) | 317.02B USD |
Diluted EPS (ttm) | 0.72 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 533.53B USD |
Total Cash Per Share (mrq) | 171.61 USD |
Total Debt (mrq) | 4.92T USD |
Total Debt/Equity (mrq) | 77.37 USD |
Current Ratio (mrq) | 0.966 |
Book Value Per Share (mrq) | 2043.7455 |
Cash Flow Statement
Operating Cash Flow (ttm) | 977.16B USD |
Levered Free Cash Flow (ttm) | 468.63B USD |
Profile of Takeda Pharmaceutical Company
Country | United States |
State | N/A |
City | Tokyo |
Address | 1-1, Nihonbashi-Honcho 2-chome |
ZIP | 103-8668 |
Phone | 81 3 3278 2111 |
Website | https://www.takeda.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab, Alofisel, Dexilant, Natpara, Adynovate/Adynovi, Takhzyro, Livtencity, Elaprase, Replagal, Advate, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, Velcade, Leuplin/Enantone, Adcetris, Vyvansese, Trintellix, and Alunbrig brands. Takeda Pharmaceutical Company Limited has out-licensing agreement with Neurocrine Biosciences, Inc.; collaborations and in-licensing agreements with the University of Texas MD Anderson Cancer Center, Arrowhead Pharmaceuticals Inc., and Ovid Therapeutics Inc.; and collaboration with Evox Therapeutics Ltd., ZEDIRA GmbH, and Dr. Falk Pharma GmbH, as well as a licensing agreement with ProThera Biologics Inc. It also has research collaboration and licensing agreement with Crescendo Biologics, Code Bio, Immusoft, Poseida Therapeutics, Selecta Biosciences, BridGene Biosciences, Skyhawk Therapeutics, and StrideBio; and strategic alliances with Egle Therapeutics SAS; Evotec SE; Neurocrine Biosciences, Inc.; Carmine Therapeutics; KSQ Therapeutics; and Anima Biotech. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan.
Q&A For Takeda Pharmaceutical Company Stock
What is a current TAK stock price?
Takeda Pharmaceutical Company TAK stock price today per share is 14.38 USD.
How to purchase Takeda Pharmaceutical Company stock?
You can buy TAK shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Takeda Pharmaceutical Company?
The stock symbol or ticker of Takeda Pharmaceutical Company is TAK.
Which industry does the Takeda Pharmaceutical Company company belong to?
The Takeda Pharmaceutical Company industry is Drug Manufacturers-Specialty & Generic.
How many shares does Takeda Pharmaceutical Company have in circulation?
The max supply of Takeda Pharmaceutical Company shares is 3.16B.
What is Takeda Pharmaceutical Company Price to Earnings Ratio (PE Ratio)?
Takeda Pharmaceutical Company PE Ratio is 32.68182000 now.
What was Takeda Pharmaceutical Company earnings per share over the trailing 12 months (TTM)?
Takeda Pharmaceutical Company EPS is 0.44 USD over the trailing 12 months.
Which sector does the Takeda Pharmaceutical Company company belong to?
The Takeda Pharmaceutical Company sector is Healthcare.
Takeda Pharmaceutical Company TAK included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NYSE COMPOSITE (DJ) NYA | 17438.64 USD — |
-1.02
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}